Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use BEOVU safely and effectively. See full prescribing information for BEOVU. BEOVU® (brolucizumab-dbll) injection, for intravitreal useInitial U.S. Approval: 2019
Medication labelWhy this: Advisory · dailymed-prescription
BEOVU® is indicated for the treatment of:
- generic_name
- brolucizumab
- product_names
- brolucizumab
- ndc
- 0078-0827, 0078-0827-61, 0078-0827-99, 0078-0827-60, 0078-0827-98
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en